Status:

COMPLETED

Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)

Lead Sponsor:

University of Alabama at Birmingham

Conditions:

Breast Cancer

Insomnia

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

In the present study, the investigators aim to investigate feasibility of utilizing noninvasive neuromodulation, specifically taVNS, as a nonpharmacologic approach to address insomnia in patients with...

Detailed Description

The study will evaluate the feasibility, safety, and tolerability of nightly, at-home self-administered taVNS treatments. Study staff will monitor for adverse reactions, unanticipated adverse device e...

Eligibility Criteria

Inclusion

  • at least 18 years of age
  • diagnosed stage I-IV breast cancer
  • self-reported difficulty falling asleep, staying asleep, or waking up too early, for at least three nights per week for a duration of at least three months
  • beginning or worsening of sleep disturbance since cancer diagnosis (did your sleep problems begin or get worse with the diagnosis of cancer or with chemotherapy?)
  • English-speaking

Exclusion

  • Are using a daily sleep aid except melatonin (use of a sleep aid as needed will be permitted, and use will be noted).
  • have a history of severe mental illness
  • have an implanted medical device of any type
  • have a history of seizures
  • have peripheral neuropathy including temporal mandibular disorders and Bells Palsy
  • have vasovagal syncope
  • have moderate to severe cognitive impairment
  • have \<6 months to live as determined by the physician

Key Trial Info

Start Date :

September 26 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 9 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06006299

Start Date

September 26 2023

End Date

July 9 2025

Last Update

October 2 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

UAB Lakeshore Collaborative (WHARF)

Birmingham, Alabama, United States, 35209

2

UAB Spain Rehabilitation Center

Birmingham, Alabama, United States, 35233